Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center : Impact on test utilization and ED length of stay

American Journal of Clinical Pathology

Volumn 129, Issue 5, 2008, Pages 796-801

  Lewandrowski, Kent ^a   Flood, James ^a   Finn, Christine ^a   Tannous, Bakhos ^a   Farris, Alton B ^a   Benzer, Theodre I ^a   Lee Lewandrowski, Elizabeth ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drugs of abuse; Emergency department; Length of stay; Point of care; Toxicology; Turnaround time

Indexed keywords

ALCOHOL; AMPHETAMINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABINOID; COCAINE; METHAMPHETAMINE; OPIATE; PHENCYCLIDINE; STREET DRUG;

ARTICLE; DRUG ABUSE; DRUG CLASSIFICATION; EMERGENCY WARD; HUMAN; LENGTH OF STAY; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TOXICOLOGY; TURNAROUND TIME; UNIVERSITY HOSPITAL; URINALYSIS; ADDICTION; EMERGENCY HEALTH SERVICE; HOSPITAL INFORMATION SYSTEM; METHODOLOGY; TIME; URINE; UTILIZATION REVIEW;

ACADEMIC MEDICAL CENTERS; EMERGENCY MEDICAL SERVICES; HUMANS; LENGTH OF STAY; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME; URINALYSIS;

EID: 44849139904     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/59681R72JDTCCD2B     Document Type: Article

References (15)

1. Bradley V. Placing emergency department crowding on the decision agenda. Nurs Econ. 2005;1:14-24.
2. Landro L. Emergency rooms hope new technology will ease their trauma. Wall Street Journal. July 13, 2001:B1.
3. Lee-Lewandrowski E, Corboy D, Lewandrowski K, et al. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center: impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med. 2003;127:456-460.
4. Murray RP, Leroux M, Sabga E, et al. Effect of point of care testing on length of stay in an adult emergency department. J Emerg Med. 1999;17:811-814.
5. Parvin C, Lo S, Deuser S, et al. Impact of point-of-care testing on patient's length of stay in a large emergency department. Clin Chem. 1996;42:711-717.
6. Kendall J, Reeves B, Clancy M. Point-of-care testing: randomized controlled trial of clinical outcome. BMJ. 1998;316:1052-1057.
7. Singer A, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med. 2005;45:587-591.
8. Blick K. Economics of point-of-care testing for cardiac markers and B-natriuretic peptide. Point of Care. 2005;4:11-14.
9. Mueller C, Scholar A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
10. Green S, Redmond P, Januzzi J, et al. The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute decompensated heart failure. Arch Pathol Lab Med. 2007;131:473-476.
11. Lewandrowski K, Pagnani G, Walsh M, et al. Evolution of point-of-care testing in a large academic teaching hospital. Point of Care. 2005;4:128-132.
12. Puopolo P, Pothier M, Volpicelli S, et al. Single procedure for detection, confirmation, and quantification of benzodiazepines in serum by liquid chromatography with photodiode-array detection. Clin Chem. 1991;37:701-706.
13. Puopolo P, Volpicelli S, Johnson D, et al. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin Chem. 1991;37:2124-2130.
14. Melanson S, Lee-Lewandrowski E, Griggs D, et al. Interpreting tricyclic antidepressant measurements in urine in an emergency setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis. J Anal Toxicol. 2007;31:270-275.
15. Melanson SF, Lee-Lewandrowski E, Griggs DA, et al. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays. Arch Pathol Lab Med. 2006;130:1834-1838.